Anna Williamson

Anna Williamson is an Executive Director in the Pharma Partnering Group at Roche, where she has 17 years of experience in Partnering and Alliance Management. In this role, she has established collaborations with companies ranging from early-stage start-ups to large Pharma. Notable partnerships she had helped establish include Genentech’s personalized cancer vaccine clinical development collaboration with BioNTech, Genentech’s clinical collaboration with Abbvie which generated Venclexta, Genentech’s cell therapy collaboration with Adaptive Biotechnologies, and Genentech’s preclinical discovery collaboration with Bicycle Therapeutics for bicyclic peptides. More recently, she led Roche’s negotiations to become a Founding Industry Member of Our Future Health, a UK-government-supported consortia for the early detection of disease. In addition to partnering, she has experience working with entrepreneurs and with academia.